세계의 흉터 치료 시장 : 흉터 유형별, 치료 유형별, 최종사용자별, 지역별 분석, 규모, 동향, COVID-19의 영향, 예측(-2030년)

Scar treatment refers to medical and cosmetic procedures aimed at reducing the appearance, size, texture, and discomfort associated with scars. These treatments help improve the skin's aesthetic appeal and restore normal function, especially in cases where scars cause tightness or restricted movement. The global scar treatment market value in 2024 stood at US$29.45 billion, and is projected to reach US$52.12 billion by 2030.

The global scar treatment market is poised for significant growth, driven by rising prevalence of skin conditions, surgeries, and trauma-related injuries that lead to scarring. Increasing consumer awareness about aesthetic appearance and the growing demand for minimally invasive and non-invasive treatment options, such as topical creams and laser therapy, are also fueling market growth. Technological advancements in laser-based treatments, dermal fillers, and regenerative medicine, along with the increasing adoption of combination therapies, are further enhancing treatment effectiveness. Additionally, the expanding medical aesthetics industry, rising disposable income, and improved access to dermatology and aesthetic clinics contribute to market expansion. Moreover, the surge in online and retail pharmacy sales, growing social media influence on skincare trends, and increasing focus on R&D for advanced scar treatment solutions are driving innovation and market penetration globally. The global scar treatment market value is projected to grow at a CAGR of 9.98%, during the forecast period of 2025-2030.

Market Segmentation Analysis:

By Scar Type: According to the report, based on scar type, the global scar treatment market can be divided into four segments: atrophic scars, hypertrophic & keloid scars, contracture scars and stretch marks. Atrophic scars segment acquired majority of share in the market in 2024 due to the high prevalence of acne scars, chickenpox scars, and surgical scars, which drive demand for treatments such as topical products, laser therapy, and microneedling. Additionally, growing consumer awareness and advancements in dermatological procedures have further boosted market dominance. Meanwhile, the stretch marks segment is expected to grow the fastest during the forecasted period, driven by increasing pregnancy rates, rising obesity levels, and growing consumer interest in aesthetic appearance. The availability of advanced treatment options, including topical creams, laser treatments, and combination therapies, along with social media influence on skincare trends, is further fueling demand for stretch mark treatments.

By Treatment Type: According to the report, based on treatment type, the global scar treatment market can be divided into four segments: topical products, laser, injectables and others. Topical products segment acquired majority of share in the market in 2024 due to its non-invasive nature, affordability, ease of application, and wide availability through retail and online pharmacies. Consumers prefer over-the-counter creams, gels, and silicone-based products for self-care and scar management, driving strong market demand. Meanwhile, the laser therapies segment is expected to grow the fastest during the forecasted period due to advancements in laser technology, increasing adoption of minimally invasive aesthetic procedures, and rising demand for effective scar reduction treatments. The growing number of dermatology and aesthetic clinics offering laser treatments, coupled with increasing consumer willingness to invest in advanced skincare solutions, is further propelling market growth.

By End-user: According to the report, the global scar treatment market is bifurcated into four types of end-users: hospitals & clinics, dermatology & aesthetic clinics and retail & online pharmacies. Hospitals & clinics segment acquired the majority share in the global scar treatment market in 2024 due to the high patient inflow for surgical scar treatments, availability of advanced medical procedures, and accessibility to specialized dermatological care. Hospitals and clinics serve as primary centers for post-surgical scar management and severe scar conditions, contributing to their dominant market share. Meanwhile, the dermatology & aesthetic clinics segment is expected to grow the fastest during the forecasted period due to the rising demand for cosmetic procedures, increasing consumer preference for specialized scar treatments, and advancements in laser and microneedling technologies. The expanding medical aesthetics industry, along with greater awareness and affordability of non-invasive scar treatments, is further driving growth in this segment.

By Region: The report provides insight into the scar treatment market based on the geographical operations, namely, North America, Europe, Asia Pacific and rest of the world. North America scar treatment market enjoyed the highest market share in 2024 due to the high prevalence of skin disorders, increased awareness of aesthetic treatments, advanced healthcare infrastructure, and strong presence of key market players. The region also benefits from high disposable income and widespread adoption of advanced scar treatment solutions, including laser therapies and injectables. Meanwhile, the Asia Pacific market is expected to grow the fastest during the forecasted period, driven by a rising population, increasing disposable income, growing beauty consciousness, and expanding access to dermatological treatments. Additionally, rapid urbanization, social media influence on skincare trends, and increasing investments in the healthcare and aesthetics industry are further propelling market growth in the region.

Global Scar treatment Market Dynamics:

Growth Drivers: One of the most important factors driving the growth of global scar treatment market is rising disposable income and increasing spending on aesthetic procedures, as higher income levels enable consumers to invest in advanced skincare solutions and cosmetic treatments. With growing economic prosperity, particularly in emerging markets, people are more willing to spend on non-essential but desirable procedures, such as laser scar removal, microneedling, and dermal fillers. Additionally, the expanding medical aesthetics industry, coupled with greater awareness of minimally invasive and non-invasive scar treatments, is driving the demand for high-quality, professional dermatological care. This trend is further amplified by the influence of social media and beauty standards, encouraging consumers to prioritize skin health and appearance. Other factors driving the growth of global scar treatment market include growing healthcare expenditure, increasing incidence of scars due to surgeries and injuries, rising prevalence of skin disorders etc.

Challenges: One significant challenge faced by the global scar treatment market is the high cost of advanced scar treatment procedures, such as laser therapy, microneedling, and injectables, which can be expensive and often require multiple sessions for optimal results. These treatments are typically not covered by insurance, making them inaccessible to a large segment of the population, particularly in developing regions. Additionally, the high cost of dermatological equipment, skilled professional fees, and post-treatment care further adds to the financial burden on consumers. As a result, many individuals opt for more affordable but less effective over-the-counter solutions, limiting the adoption of advanced scar treatment technologies. Another challenge might include regulatory scenario etc.

Trends: The adoption of minimally invasive techniques is a significant trend in the global scar treatment market, driven by growing consumer preference for effective yet less painful and low-risk procedures. Advanced treatments such as laser therapy, microneedling, and dermal fillers offer noticeable scar reduction with minimal downtime, making them popular among individuals seeking aesthetic improvements without undergoing surgery. Additionally, technological advancements in laser systems and regenerative medicine have enhanced treatment precision and outcomes, further fueling demand. As awareness of these options grows and dermatology clinics expand their service offerings, minimally invasive scar treatments are becoming more accessible and widely adopted worldwide. The market is also projected to grow at a fast pace during the forecast period, due to various other latest trends such as rise in adoption of artificial intelligence, technological advancements in laser therapy and energy-based devices, rising adoption of biologics and regenerative medicine, growing preference for natural and organic scar treatment products, medical tourism etc.

Impact Analysis of COVID-19 and Way Forward:

The global scar treatment market experienced a temporary slowdown during the COVID-19 pandemic due to disruptions in dermatology and aesthetic procedures, supply chain challenges, and reduced consumer spending on non-essential treatments. However, post-pandemic, the market rebounded with increased demand for scar treatment products and procedures, driven by growing aesthetic consciousness, the rise of online consultations, and improved access to advanced treatment options.

Competitive Landscape and Recent Developments:

The global scar treatment market is characterized as moderately fragmented, with a mix of large multinational companies and smaller regional players. Key players such as Mederma (Perrigo Company Plc), Smith+Nephew, Alliance Pharmaceuticals Limited, Molnlycke Health Care AB, and Bausch Health Inc. hold a significant share of the market, particularly in terms of advanced treatments and global reach. However, the presence of numerous niche and regional players, especially in emerging markets, contributes to the market's fragmented nature. Key players of global scar treatment market are:

Smith & Nephew Plc

Bausch Health Companies Inc.

Molnlycke AB

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Sonoma Pharmaceuticals, Inc.

Perrigo Company plc

Alliance Pharma plc

Merz Pharma GmbH & Co. KGaA

Candela Medical

Cynosure

CCA Industries, Inc.

NewMedical Technology, Inc.

The key players are constantly investing in strategic initiatives, such as adoption of new technologies, introducing their products to emerging markets and more, to maintain a competitive edge in this market. For instance, In January 2024, Bausch Health announced that its Solta Medical's Thermage(R) FLX received registration certifications in China. This non-invasive treatment uses radiofrequency technology to improve skin texture and smoothness, contributing to scar management by optimizing patients' appearances.

Table of Contents

1. Executive Summary

2. Introduction

• 2.1 Scar Treatment: An Overview
  • 2.1.1 Introduction to Scar Treatment
  • 2.1.2 Why Does Scar Treatment Matter?
• 2.2 Scar Treatment Segmentation: An Overview
  • 2.2.1 Scar Treatment Segmentation

3. Global Market Analysis

• 3.1 Global Scar Treatment Market: An Analysis
  • 3.1.1 Global Scar Treatment Market: An Overview
  • 3.1.2 Global Scar Treatment Market by Value
  • 3.1.3 Global Scar Treatment Market by Scar Type (Atrophic Scars, Hypertrophic & Keloid Scars, Contracture Scars and Stretch Marks)
  • 3.1.4 Global Scar Treatment Market by Treatment Type (Topical Products, Laser, Injectables and Others)
  • 3.1.5 Global Scar Treatment Market by End-user (Hospitals & Clinics, Dermatology & Aesthetic Clinics and Retail & Online Pharmacies)
  • 3.1.6 Global Scar Treatment Market by Region (North America, Europe, Asia Pacific and Rest of the World)
• 3.2 Global Scar Treatment Market: Scar Type Analysis
  • 3.2.1 Global Scar Treatment Market by Scar Type: An Overview
  • 3.2.2 Global Atrophic Scar Treatment Market by Value
  • 3.2.3 Global Hypertrophic & Keloid Scar Treatment Market by Value
  • 3.2.4 Global Contracture Scar Treatment Market by Value
  • 3.2.5 Global Stretch Marks Scar Treatment Market by Value
• 3.3 Global Scar Treatment Market: Treatment Type Analysis
  • 3.3.1 Global Scar Treatment Market by Treatment Type: An Overview
  • 3.3.2 Global Topical Products Scar Treatment Market by Value
  • 3.3.3 Global Laser Based Scar Treatment Market by Value
  • 3.3.4 Global Injectables Scar Treatment Market by Value
  • 3.3.5 Global Other Scar Treatment Market by Value
• 3.4 Global Scar Treatment Market: End-user Analysis
  • 3.4.1 Global Scar Treatment Market by End-user: An Overview
  • 3.4.2 Global Hospitals & Clinics Scar Treatment Market by Value
  • 3.4.3 Global Dermatology & Aesthetic Clinics Scar Treatment Market by Value
  • 3.4.4 Global Retail & Online Pharmacies Scar Treatment Market by Value

4. Regional Market Analysis

• 4.1 North America Scar Treatment Market: An Analysis
  • 4.1.1 North America Scar Treatment Market: An Overview
  • 4.1.2 North America Scar Treatment Market by Value
  • 4.1.3 North America Scar Treatment Market by Region (The US, Canada and Mexico)
  • 4.1.4 The US Scar Treatment Market by Value
  • 4.1.5 Canada Scar Treatment Market by Value
  • 4.1.6 Mexico Scar Treatment Market by Value
• 4.2 Europe Scar Treatment Market: An Analysis
  • 4.2.1 Europe Scar Treatment Market: An Overview
  • 4.2.2 Europe Scar Treatment Market by Value
  • 4.2.3 Europe Scar Treatment Market by Region (Germany, UK, France, Italy, Spain and Rest of Europe)
  • 4.2.4 Germany Scar Treatment Market by Value
  • 4.2.5 United Kingdom Scar Treatment Market by Value
  • 4.2.6 France Scar Treatment Market by Value
  • 4.2.7 Italy Scar Treatment Market by Value
  • 4.2.8 Spain Scar Treatment Market by Value
  • 4.2.9 Rest of Europe Scar Treatment Market by Value
• 4.3 Asia Pacific Scar Treatment Market: An Analysis
  • 4.3.1 Asia Pacific Scar Treatment Market: An Overview
  • 4.3.2 Asia Pacific Scar Treatment Market by Value
  • 4.3.3 Asia Pacific Scar Treatment Market by Region (China, Japan, India, South Korea and Rest of Asia Pacific)
  • 4.3.4 China Scar Treatment Market by Value
  • 4.3.5 Japan Scar Treatment Market by Value
  • 4.3.6 India Scar Treatment Market by Value
  • 4.3.7 South Korea Scar Treatment Market by Value
  • 4.3.8 Rest of Asia Pacific Scar Treatment Market by Value
• 4.4 Rest of the World Scar Treatment Market: An Analysis
  • 4.4.1 Rest of the World Scar Treatment Market: An Overview
  • 4.4.2 Rest of the World Scar Treatment Market by Value

5. Impact of COVID-19

• 5.1 Impact of COVID-19 on Scar Treatment Market
• 5.2 Post COVID-19 Impact on Scar Treatment Market

6. Market Dynamics

• 6.1 Growth Drivers
  • 6.1.1 Rising Disposable Income and Spending on Aesthetic Procedures
  • 6.1.2 Growing Healthcare Expenditure
  • 6.1.3 Rising Social Media Influence
  • 6.1.4 Increasing Incidence of Scars Due to Surgeries and Injuries
  • 6.1.5 Rising Prevalence of Skin Disorders
  • 6.1.6 Growing Popularity Of Non-invasive (Minimally-invasive) Treatments
• 6.2 Challenges
  • 6.2.1 High Cost of Advanced Scar Treatment Procedures
  • 6.2.2 Regulatory Scenario
• 6.3 Market Trends
  • 6.3.1 Rise in Adoption of Artificial Intelligence
  • 6.3.2 Rising Adoption of Biologics and Regenerative Medicine
  • 6.3.3 Growing Preference for Natural and Organic Scar Treatment Products
  • 6.3.4 Advancements in Laser Therapy and Energy-Based Devices
  • 6.3.5 Medical Tourism

7. Competitive Landscape

• 7.1 Global Scar Treatment Market Players: Recent Developments

8. Company Profiles

• 8.1 Smith & Nephew Plc
  • 8.1.1 Business Overview
  • 8.1.2 Operating Segments
  • 8.1.3 Business Strategies
• 8.2 Bausch Health Companies Inc.
  • 8.2.1 Business Overview
  • 8.2.2 Operating Segments
  • 8.2.3 Business Strategy
• 8.3 Molnlycke AB
  • 8.3.1 Business Overview
  • 8.3.2 Operating Segments
  • 8.3.3 Business Strategy
• 8.4 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
  • 8.4.1 Business Overview
  • 8.4.2 Operating Segments
  • 8.4.3 Business Strategy
• 8.5 Sonoma Pharmaceuticals, Inc.
  • 8.5.1 Business Overview
  • 8.5.2 Operating Regions
  • 8.5.3 Business Strategy
• 8.6 Perrigo Company plc
  • 8.6.1 Business Overview
  • 8.6.2 Operating Segments
  • 8.6.3 Business Strategy
• 8.7 Alliance Pharma plc
  • 8.7.1 Business Overview
  • 8.7.2 Operating Segments
• 8.8 Merz Pharma GmbH & Co. KGaA
  • 8.8.1 Business Overview
  • 8.8.2 Business Strategy
• 8.9 Candela
  • 8.9.1 Business Overview
  • 8.9.2 Business Strategy
• 8.10 Cynosure
  • 8.10.1 Business Overview
  • 8.10.2 Business Strategy
• 8.11 CCA Industries, Inc.
  • 8.11.1 Business Overview
  • 8.11.2 Business Strategy
• 8.12 NewMedical Technology, Inc.
  • 8.12.1 Business Overview